Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments

Academic Emergency Medicine

Volumn 16, Issue 4, 2009, Pages 316-324

  Rowe, Brian H ^a,b   Villa Roel, Cristina ^a   Guttman, Alex ^c   Ross, Scott ^d   Mackey, Duncan ^e   Sivilotti, Marco L A ^f   Worster, Andrew ^g   Stiell, Ian G ^h   Willis, Virginia ^a   Borgundvaag, Bjug ⁱ  

^a UNIVERSITY OF ALBERTA   (Canada)

^b University Terrace   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Department of Emergency Medicine   (Canada)

^e Lethbridge Regional Hospital   (Canada)

^f QUEEN S UNIVERSITY   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

^h OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

ⁱ MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Admission; Chronic obstructive pulmonary disease; Emergency department; Exacerbation

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID;

ADULT; AGE; AGED; AIRWAY OBSTRUCTION; ANAMNESIS; ARTICLE; BREATHING RATE; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG USE; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PHYSICAL CAPACITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK REDUCTION; STRUCTURED INTERVIEW; TELEPHONE;

ADULT; AGED; AGED, 80 AND OVER; CANADA; CHOLINERGIC ANTAGONISTS; CROSS-SECTIONAL STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INTERVIEWS AS TOPIC; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 65249170940     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2009.00366.x     Document Type: Article

References (33)

1. Pauwels RA, Buist AS, Calverley PM, Jenins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001; 163:1256-76.
2. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary. Am J Respir Crit Care Med. 2007; 176:532-55.
3. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006; 28:523-32.
4. National Heart Lung and Blood Institute. Morbidity and Mortality: Chartbook on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: Harvard University Press, 1998.
5. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997; 349:1498-504.
6. World Health Organization. World Health Report. Geneva, Switzerland: WHO, 2000. Available at: http://www.who.int/whr/2000. Accessed Jan 14, 2009.
7. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: The Nippon COPD epidemiology study. Res- pirology. 2004; 9:458-65.
8. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006; 27:188-207.
9. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ. 2002; 51(6):1-16.
10. Garcia-Aymerich J, Monso E, Marrades RM, et al. Risk Factors for Hospitalization for a Chronic Obstructive Pulmonary Disease Exacerbation (EFRAM STUDY). Am J Respir Crit Care Med. 2001; 164:1002-7.
11. Cydulka RK, Rowe BH, Clark S, Emerman CL, Rimm AR, Camargo CA Jr. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation. Acad Emerg Med. 2005; 12:1173-9.
12. Tsai CL, Clark S, Cydulka RK, Rowe BH, Camargo CA Jr. Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation. Acad Emerg Med. 2007; 14:6-15.
13. Smithline HA, Rowe BH, Radeos MS, Cydulka RK, Camargo CA Jr. Research opportunities in the management of acute exacerbations of chronic obstructive pulmonary disease. Acad Emerg Med. 2005; 12:742-50.
14. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000; 5(Suppl 2):398S-401S.
15. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J. 2003; 41:46S-53S.
16. Beveridge R. The Canadian Triage and Acuity Scale: a new and critical element in health care reform. J Emerg Med. 1998; 16:507-11.
17. Anthonisen N, Manfreda J, Warren P, Hershfield E, Harding G, Nelson N. Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease. Ann Intern Med. 1987; 106:196-204.
18. Soriano JR, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax. 2000; 55:789-94.
19. National Heart Lung and Blood Institute. Morbidity and Mortality Chartbook on Cardiovascular, Lung and Blood Diseases. Bethesda, MD: Harvard University Press, 2004.
20. Xu X, Weiss ST, Rijcken B, Schouten JP. Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. Eur Respir J. 1994; 7:1056-61.
21. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994; 272:1497-505.
22. Silverman EK, Weiss ST, Drazen JM, et al. Gender- related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 162:2152-8.
23. Kessler R, Faller M, Fourgaut G, Mennecier B, We- itzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 159:158-64.
24. Anthonisen NR. Smoking, lung function and mortality. Thorax. 2000; 55:729-30.
25. Petty TL. COPD in perspective. Chest. 2002; 121:116S-20S.
26. Siafakis NM, Vermeire P, Pride NB, et al. ERS-con- sensus statement. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J. 1995; 8:1398-420.
27. Petty TL. Scope of the COPD problem in North America: early studies of prevalence and NHANES III data: basis for early identification and intervention. Chest. 2000; 5(Suppl 2):326S-31S.
28. Lundback B, Gulsvik A, Albers M, et al. Epidemio- logical aspects and early detection of chronic obstructive airway diseases in the elderly. Eur Respir J. 2003; 40:3S-9S.
29. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157:1418-22.
30. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA. Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax. 2003; 58:654-8.
31. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propi- onate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000; 320:1297-303.
32. Kim S, Emerman CL, Cydulka RK, Rowe BH, Clark S, Camargo CA Jr. Prospective multicenter study of relapse following emergency department treatment of COPD exacerbation. Chest. 2004; 125:473-81.
33. Rowe BH, Bond B, Ospina MB, et al. Frequency, determinants, and impact of overcrowding in emergency departments in Canada: a national survey of emergency department directors. Ottawa, Canada: Canadian Agency for Drug and Technologies in Health; 2006. Report No.: [Technology reports issue 67.3].